References
- FDA news Drug Pipeline Alert, March 21, (2006), 4, No. 56.
- Burden DA, Osheroff N. Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme. Biochim Biophys Acta 1998; 1400:139–154.
- Tomita K, Tsuzuki Y, Shibamori K, Tashima M, Kajikawa F, Sato Y, Kashimoto S, Chiba K, Hino K. Synthesis and structure-activity relationships of novel 7-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acids as antitumor agents. Part 1. J Med Chem (2002); 45(25): 5564–5575.
- Tsuzuki Y, Tomita K, Shibamori K, Sato Y, Kashimoto S, Chiba K. Synthesis and structure-activity relationships of novel 7-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acids as antitumor agents. Part 2. J Med Chem (2004); 47(8): 2097–2109.
- Kumar V, Mudgal, MM, Rani N, Jha A, Jaggi M, Singh AT, Sanna VK, Singh P, Sharma PK, Irchhaiya R, Burman AC. Synthesis of functionalized amino acid derivatives as new pharmacophores for designing anticancer agents. J Enz Inhib Med Chem (2008) -In press.
- Burden DA, Oshereroff N. Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme. Biochim Biophys Acta (1998); 1400:139–154.
- Coussens LM, Werb Z. Inflammation and cancer. Nature (2002); 420:860–867.
- Grossi G, Di Braccio M, Roma G, Ballabeni V, Tognolini M, Barocelli E. 1,8-Naphthyridines v. novel N-substituted 5-amino-N,N-diethyl-9-isopropyl [1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6-carboxamides, as potent anti-inflammatory and/or analgesic agents completely devoid of acute gastrolesivity. Eur J Med Chem (2005); 40: 155–165.
- Dianzani C, Collino M, Gallicchio M, Di Braccio M, Roma G, Fantozzi R. Effects of anti-inflammatory [1, 2, 4]triazolo[4, 3-a] [1, 8]naphthyridine derivatives on human stimulated PMN and endothelial cells: an in vitro study. J Inflamm (2006); 3: 4–14.
- Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth (1983); 65: 55–63.
- Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Meth (1999); 223: 77–92.